Neuroscientists reveal that the part of the brain that receives and processes visual information in sighted people develops a unique connectivity pattern in people born blind. They say this pattern in the primary visual cortex is unique to each person -- akin to a fingerprint. A study led by Georgetown University neuroscientists reveals that the
Drug repurposing shows promise in the treatment of retinal degenerations, according to a new study. A combination treatment incorporating three existing drugs -- tamsulosin, metoprolol and bromocriptine -- slowed disease progression in pre-clinical retinopathy models. Drug repurposing shows promise in the treatment of retinal degenerations, according to a new study by an international team of
Neuroscientists reveal that the part of the brain that receives and processes visual information in sighted people develops a unique connectivity pattern in people born blind. They say this pattern in the primary visual cortex is unique to each person -- akin to a fingerprint. A study led by Georgetown University neuroscientists reveals that the
Neuroscientists reveal that the part of the brain that receives and processes visual information in sighted people develops a unique connectivity pattern in people born blind. They say this pattern in the primary visual cortex is unique to each person -- akin to a fingerprint. A study led by Georgetown University neuroscientists reveals that the
When doctors sit at hospitalized patients' bedsides, it can have a more positive impact than if they stand, a review of data suggests -- but a new study seeks to find out for sure. Doctors and others who take care of hospitalized patients may want to sit down for this piece of news. A new
Drug repurposing shows promise in the treatment of retinal degenerations, according to a new study. A combination treatment incorporating three existing drugs -- tamsulosin, metoprolol and bromocriptine -- slowed disease progression in pre-clinical retinopathy models. Drug repurposing shows promise in the treatment of retinal degenerations, according to a new study by an international team of
Unveils the potential of adoptive therapy in treating this challenging cancer. With its rare and aggressive nature, metastatic uveal melanoma has long thwarted traditional treatments. However, the innovative approach of growing a patient's T cells outside the body before reinfusing them has shown promising results. This groundbreaking research offers hope for patients with this resilient form of cancer, shedding light on a potential breakthrough in the field of oncology
The forefront of ophthalmic imaging have harnessed the power of AI to revolutionize cell imaging in the eye. The use of AI has accelerated imaging speed and enhanced image quality, making it a vital tool for evaluating age-related macular degeneration and other retinal diseases. This innovation promises to significantly improve the efficiency and accuracy of research in this critical area of ophthalmology
